Amanda Nesbett is a Lufkin, Texas based nurse practitioner. Active license number of Amanda Nesbett is 1072626 for Family in Texas. Her current practice location is 206 Gene Samford Dr, Lufkin. Patients can reach her at 936-634-3396 or can fax her at 936-632-7933 and her NPI number (Unique professional ID assigned by NPPES) is 1295482156. Amanda Nesbett has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Amanda Nesbett speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1295482156
NPI Enumeration Date:
09 Mar, 2022
NPI Last Update On:
01 Aug, 2025
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Amanda Nesbett are as mentioned below.
License Number
Specialization
State
Status
1072626
Family
Texas
Primary
1072626
Family Medicine
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Amanda Nesbett 206 Gene Samford Dr, Lufkin, Texas
Zip:
75904-3358
Phone Number:
936-634-3396
Fax Number:
936-632-7933
Patients can reach Amanda Nesbett at 206 Gene Samford Dr, Lufkin, Texas or can call to book an appointment on 936-634-3396.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.